skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines caplacizumabQuestion & answer

caplacizumab · Medicine question

Why is it combined with plasma exchange and immunosuppression?

iatroX medicinesPublished 19 August 2026Reviewed 19 August 2026

The answer

Answer

Caplacizumab rapidly limits platelet-rich microclots, while plasma exchange and immunosuppression address the underlying immune process.

Sources for this answer

Cablivi 10 mg powder and solvent for solution for injectionemc · SmPC Current selected SmPC · Version 10
PubMedPubMed · Reputable Web

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

caplacizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the caplacizumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX

More questions about caplacizumab

Is caplacizumab a blood thinner?Can caplacizumab be self-injected?What should I tell a dentist or surgeon?How should caplacizumab be stored at home?